Iroko Pharmaceuticals gains FDA approval of ZORVOLEX® for management of osteoarthritis pain

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced the United States Food and Drug Administration (FDA) has...
Pain / Anesthetics News From Medical News Today

Share:

Related Content